Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09FLC
|
||||
| Former ID |
DNC010084
|
||||
| Drug Name |
17-Methylmorphinan-3-yl 4-Iodophenyl Carbamate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530529] | ||
| Formula |
C24H27IN2O2
|
||||
| Canonical SMILES |
CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC(=O)NC5=CC=C(C=C5)I
|
||||
| InChI |
1S/C24H27IN2O2/c1-27-13-12-24-11-3-2-4-20(24)22(27)14-16-5-10-19(15-21(16)24)29-23(28)26-18-8-6-17(25)7-9-18/h5-10,15,20,22H,2-4,11-14H2,1H3,(H,26,28)/t20-,22+,24+/m0/s1
|
||||
| InChIKey |
YGDGBZQTGCWFHN-BGWNEDDSSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [530529] | |
| Kappa-type opioid receptor | Target Info | Inhibitor | [530529] | ||
| Mu-type opioid receptor | Target Info | Inhibitor | [530529] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.